DHODH and cancer: Inhibition of dihydroorotate dehydrogenase (DHODH) which contributes to mitochondrial electron transport chain [31] and catalyzes conversion of dihydroorotate into orotate is regarded as a promising therapy to treat patients with Pten mutant cancers [32].